Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Clinical trial NCT01058642 · TERMINATED
Trial details
- NCT number
- NCT01058642
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.